Notably, VUMC is one of a very few centers that evaluates the effects of such tools on health outcomes. The combined strength of this infrastructure with a large group of clinical and research faculty members working in evidence translation secured VUMCs designation as an EPC.
Our facultys strength was clearly endorsed in this competitive process. Were one of 14. This selection says that the AHRQ believes we have top notch scientists and a strong infrastructure to produce scientifically rigorous reports and materials to help inform care, said Katherine Hartmann, M.D., Ph.D., director of the EPC. Vanderbilt is on the leading edge of moving evidence into practice. Being designated an EPC is an accomplishment for us all to celebrate.
VUMCs EPC will participate in two key aspects of the Evidence-based Practice Program: Generalist Reviews and Comparative Evidence Reviews. Generalist topics are broad and typically handle management of specific conditions. Comparative Effectiveness Reviews are more targeted reviews of specific drugs or devices that have an explicit focus on the development of broadly accessible materials for patients, physicians and policy makers.
AHRQ is the federal agency that studies quality of care and use of evidence in health care. They are mandated to determine what the best evidence is, so that health care providers and payers can put the best evidence into practice for patients. It is exciting to be part of that process, said Melissa McPheeters, Ph.D., MPH, of the Institute for Medicine and Public Health at VUMC and associate director for operations for Vanderbilts EPC.
Other center locations include Johns Hopkins University, Duke University and the Research Triangle Institute an
|Contact: Craig Boerner|
Vanderbilt University Medical Center